![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, December 27, 2014 6:06:32 AM
Being invested in a story stock (DECN – versus J&J) has as usual it’s up and downs and every investor
Is looking for news that will mean an end to the ongoing saga, especially when the counter-party your
Are fighting against is a AAA multi-billion Dollar company. And despite all the hopplas, the stock did
Not that badly versus the S&P Index during the last 3 years as can see with the Correlation-Indicator.
We saw outperformance and underperformance, but not “underperformance” as such. In short: Since
DECN got the FDA Approval in late 2012, the stock did not that badly (as shown with a sep. chart) The
Weekly volume tells the story – the next time, the volume leaves the declining pattern, the story will
Be out and DECN I would guess, on it’s way to execute business.
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM